Condition
PTSD
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 42 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
42 shownTesting an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 TrialNCT07010757 · 2026-03-02
RECRUITINGBehavioral Health Collaborative Care Model in an ICU Recovery ClinicNCT07372586 · 2026-01-30
RECRUITINGBehavioral Health Collaborative Care Model in Post-ICU Clinic Family PilotNCT07390786 · 2026-01-30
RECRUITINGEnhancing Rehabilitation for Veterans With Serious Mental IllnessNCT06586164 · 2025-02-25
RECRUITINGOpen-Label Psilocybin Study in Transdiagnostic PopulationNCT06442423 · 2024-10-17
RECRUITINGEffectiveness of Trauma Therapy Using Prolonged Exposure for Patients With PTSD and a Comorbid Psychotic DisorderNCT06048172 · 2023-05-15
RECRUITINGNYSCF Scientific Discovery BiobankNCT06203106 · 2022-11-10
RECRUITINGAssessing of Behavioral Risk and Response to Electromagnetic and Psychedelic TherapiesNCT07745569 · 2026-08-31
NOT_YET_RECRUITINGUsing Integrated Care and Wearable Technology to Evaluate Outcomes of the Shields & Stripes Program for Veterans and First RespondersNCT07452900 · 2026-04-01
NOT_YET_RECRUITINGEnhancing Operational Readiness With Digital Self-Managed Cognitive Behavioral Therapy for Insomnia (CBTI)NCT07335276 · 2026-03-01
NOT_YET_RECRUITINGThe Sequestration of Holistic Stress Management Techniques for AdultsNCT06098755 · 2026-01-26
WITHDRAWNEvaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic InsomniaNCT06644573 · 2025-11-01
NOT_YET_RECRUITINGThe Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.NCT06993662 · 2025-06-02
COMPLETEDComputer Game, Qualitative, and MEG/EEG Assessment of Serotonergic PsychedelicsNCT06624137 · 2024-12-12
TERMINATEDTesting a Transdiagnostic TMS Treatment TargetNCT06282146 · 2024-09-09
COMPLETEDFirst-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM)NCT05921929 · 2024-05-02
WITHDRAWNPsychiatric Orders in Psychoanalytic Treatment of ASDNCT05930912 · 2023-06-01
UNKNOWNFeasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSDNCT05717439 · 2023-03-01
COMPLETEDI MOVE!+UP: Piloting an Integrated Weight Management Program for Veterans With PTSDNCT05755100 · 2023-01-12
COMPLETEDCPT-L to Improve Outcomes for Individuals With HIV and PTSDNCT05275842 · 2022-07-13
COMPLETEDStrengthening Families Living With HIV in KenyaNCT04588883 · 2021-09-28
COMPLETEDEffectiveness of Trauma Therapy in Patients With PTSD and Comorbid Psychotic DisorderNCT04911010 · 2021-01-20
UNKNOWNWriting to Alleviate Violence Exposure for Transgender Women (WAVE-TW)NCT04305977 · 2020-10-22
WITHDRAWNMOVE!+UP: Testing a Tailored Weight Management Program for Veterans With PTSDNCT04563741 · 2020-10-01
COMPLETEDAssessing Inflammatory and Behavioral Pathways Linking PTSD to Increased Asthma Morbidity in WTC WorkersNCT04552301 · 2020-08-18
COMPLETEDIntervention Program to Address PTSD in People Living With HIVNCT05588596 · 2020-05-03
COMPLETEDExtreme Challenges - Psychopathology & Treatment Experiences Among Severly Selfharming Inpatients in NorwayNCT03768674 · 2019-10-01
COMPLETEDEfficacy of EMDR Therapy, as Compared to Treatment as Usual, in Reducing Clinical Symptoms in People With HIVNCT03848858 · 2019-02-01
COMPLETEDChildhood Maltreatment, Traumatic Experiences and Stress-associated Parameters in Schizophrenia Spectrum DisordersNCT03730831 · 2018-01-01
COMPLETEDMcLean and Genomind Prospective StudyNCT03113890 · 2017-09-22
COMPLETEDProcedures for Sample Acquisition and Distribution for The Human Brain Collection CoreNCT03092687 · 2017-03-21
TERMINATEDThe Treatment of Depression With Yoga and WalkingNCT02907476 · 2017-01-04
COMPLETEDCognitive-behavioral Therapy for Treatment of Post-traumatic Stress Disorder and Related ProblemsNCT03019497 · 2017-01-01
COMPLETEDWhole Body Hyperthermia Registry StudyNCT02174003 · 2014-06-01
TERMINATEDDental Status of Patients With Severe Mental IllnessNCT01315509 · 2011-04-01
COMPLETEDEvaluation of Generalization Paradigm Patterns Among Different Psychiatric DisordersNCT01501812 · 2011-03-01
UNKNOWNImproving Obesity Self-Care Among Mentally Ill VeteransNCT02642536 · 2011-01-01
COMPLETEDCognitive Training to Enhance VA Work Program OutcomesNCT00829400 · 2008-05-01
COMPLETEDSchizophrenia and PTSD Project: Health, Interventions, and Risk/Resilience Evaluation(SAPPHIRE Study)NCT00560677 · 2007-03-01
UNKNOWNPTSD and Risk Behavior in HIV Positive Female AdolescentsNCT00271882 · 2006-03-01
COMPLETEDEvaluation Study of TIDES Depression Care Quality Improvement InterventionNCT00105820 · 2003-06-01
COMPLETEDReducing Risk and Trauma-Related Stress in Persons Living With HIVNCT00186030 · 2003-04-01
TERMINATEDCommon interventions
Cognitive behavioral therapyBEHAVIORAL2Prolonged ExposureBEHAVIORAL2Anesthesia-Induced Sleep TherapyPROCEDURE1Assessment of diagnoses, functioning and health servicesOTHER1Behavioral Health Collaborative Care ModelBEHAVIORAL1Behavioral TreatmentBEHAVIORAL1Biological Sample CollectionOTHER1CAPS-5-RDIAGNOSTIC_TEST1Cheek SwabGENETIC1Cognitive Behavioral Therapy for InsomniaBEHAVIORAL1Cognitive Processing TherapyBEHAVIORAL1Cognitive Processing Therapy- Lifesteps (CPT-L)BEHAVIORAL1Cognitive RemediationBEHAVIORAL1Continuous EEG MonitoringDEVICE1control arm for HARPP trialBEHAVIORAL1Diprivan (propofol), Astra-ZenecaDRUG1Duloxetine 20 MGDRUG1EMDR plus TAUBEHAVIORAL1Enhanced Usual CareBEHAVIORAL1Fluoroethylnormemantine (FENM)DRUG1General Asthma EducationBEHAVIORAL1Generalization patternBEHAVIORAL1Group A. The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by anxiety disorders and depression.COMBINATION_PRODUCT1Group B. The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by PTSDCOMBINATION_PRODUCT1Group C. The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by obsessive-compulsive disorder.COMBINATION_PRODUCT1
Leading sponsors
VA Office of Research and Development
4
Medical University of South Carolina
3
Yale University
2
Baylor University
1
Boston University
1
Brigham and Women's Hospital
1
Central South University
1
Durham VA Medical Center
1
Goddess Zena I. Jones
1
Hadassah Medical Organization
1
Icahn School of Medicine at Mount Sinai
1
Madigan Army Medical Center
1
Mclean Hospital
1
Medicalschool Hamburg
1
National Institute of Mental Health (NIMH)
1
Trial status mix
COMPLETED20
RECRUITING7
NOT_YET_RECRUITING4
TERMINATED4
UNKNOWN4
WITHDRAWN3
Phase mix
NA23
PHASE15
PHASE22
EARLY_PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.